is tirzepatide being discontinued In a 69-year-old man who discontinued tirzepatide (Zepbound) after six months Is Zepbound Being Discontinued? Weight

Completion of an evaluation does not guarantee prescription approval

Combination of peptide YY3-36 with GLP-1(7-36) amide causes an increase in first-phase insulin secretion after IV glucose

If you have experienced recurring chest pain that your cardiologist has ruled as non-cardiac, it is time to look at your digestive health

Ozempic and Mounjaro are currently FDA-approved only to treat type 2 diabetes, while Wegovy is FDA-approved for weight loss

A cautionary note on GLP-1-based pharmacology is the limitation on dose escalation due to corresponding increases in gastrointestinal tolerability issues

Hypertension is also linked to an elevated overall risk of endometrial cancer [23]